text
"['\n1. 요약재무정보\n※ 아래의 제61기 3분기 요약재무정보는 한국채택국제회계기준 작성기준에 따라 작성되었으며 외부회계법인의 검토를 받은 재무정보입니다.\xa0\n\xa01.연결요약재무상태표 , 연결요약손익계산서\xa0\xa0\xa0 * 비교표시된 전기 및 전전기 재무정보는 재작성된 재무정보입니다.\n(단위 : 천원)\n구 분\n제61기3분기\n제60기(재작성)\n제59기(재작성)\n[유동자산]\n340,526,229\n313,620,339\n337,927,936\n\xa0ㆍ매출채권및\xa0 \xa0 \xa0 \xa0 기타수취채권\n180,953,655\n181,408,264\n188,003,265\n\xa0ㆍ기타유동자산\n159,572,574\n132,212,075\n149,924,671\n[비유동자산]\n537,842,707\n531,664,914\n580,152,389\n\xa0ㆍ투자부동산\n126,744,096\n126,090,822\n111,819,179\n\xa0ㆍ기타비유동자산\n411,098,611\n\xa0 \xa0 \xa0 \xa0\xa0 405,574,092\n468,333,210\n자산총계\n878,368,936\n845,285,253\n918,080,325\n[유동부채]\n332,107,173\n313,828,871\n280,976,703\n\xa0ㆍ매입채무및\xa0 \xa0 \xa0 \xa0 기타채무\n169,997,546\n180,052,889\n162,226,047\n\xa0ㆍ기타유동부채\n162,109,627\n\xa0 \xa0 \xa0 \xa0\xa0 133,775,982\n118,750,656\n[비유동부채]\n53,494,362\n49,608,600\n49,532,823\n부채총계\n385,601,535\n363,437,471\n330,509,526\n[자본금]\n7,986,678\n7,986,678\n7,986,678\n[자본잉여금]\n251,662,951\n251,661,314\n256,162,295\n[기타자본항목]\n(66,782,954)\n(66,782,954)\n(66,782,954)\n[기타포괄손익]\n35,756,103\n35,722,704\n34,120,772\n[이익잉여금]\n172,550,654\n164,620,330\n257,870,360\n[비지배지분]\n91,593,969\n88,639,711\n98,213,648\n자본총계\n492,767,401\n481,847,783\n587,570,799\n종속.관계.공동기업투자주식의 평가방법\r\n지분법\xa0\n지분법\xa0\n지분법\xa0\n(2020.1.1.~2020.09.30\n(2019.1.1.~2019.12.31\n(2018.1.1.~2018.12.31)\n매출액\n571,966,911\n731,804,976\n141,765,834\n영업이익\n19,015,015\n9,530,309\n9,849,524\n당기순이익\n12,195,276\n(95,508,835)\n1,305,242\n\xa0 지배기업 소유주지분\n8,766,070\n(90,492,111)\n4,149,849\n\xa0 비지배지분\n3,429,206\n(5,016,724)\n(2,844,608)\n기타포괄손익\n272,233\n392,034\n24,257,819\n총포괄손익\n12,467,509\n(95,900,869)\n25,563,061\n\xa0 지배기업 소유주지분\n9,032,784\n(90,561,447)\n23,346,429\n\xa0 비지배지분\n3,434,725\n(5,339,422)\n2,216,632\n기본주당이익(원)\n571\n(5,895)\n800\n희석주당이익(원)\n571\n(5,895)\n800\n연결에 포함된 회사수\n4\n3\n3\n\xa0* 연결에 추가 포함된 회사는 종속회사인 제일약품(주)의 종속회사인 온코닉 테라퓨틱스가 추가된 것임\xa02.요약별도재무상태표 , 요약별도손익계산서\xa0 \xa0\xa0\n(단위 : 천원)\n구 분\n제61기3분기\n제60기\n제59기\n[유동자산]\n10,748,859\n21,794,581\n37,229,196\n\xa0ㆍ매출채권및\xa0 \xa0 \xa0 \xa0 기타수취채권\n1,817,857\n10,878,693\n1,949,813\n\xa0ㆍ기타유동자산\n8,931,002\n10,915,888\n35,279,383\n[비유동자산]\n510,154,592\n507,185,804\n550,172,889\n\xa0ㆍ투자부동산\n154,558,624\n155,472,470\n111,819,179\n\xa0ㆍ기타비유동자산\n355,595,968\n351,713,334\n438,353,710\n자산총계\n520,903,451\n528,980,385\n587,402,085\n[유동부채]\n87,161,023\n100,367,762\n76,332,942\n\xa0ㆍ매입채무및\xa0 \xa0 \xa0 \xa0 기타채무\n1,051,005\n9,634,635\n1,059,416\n\xa0ㆍ기타유동부채\n86,110,018\n90,733,127\n75,273,526\n[비유동부채]\n31,387,983\n31,093,839\n26,562,424\n부채총계\n118,549,006\n131,461,601\n102,895,366\n[자본금]\n7,986,678\n7,986,678\n7,986,678\n[자본잉여금]\n254,487,379\n254,487,379\n254,487,379\n[기타자본항목]\n(66,782,954)\n(66,782,954)\n(66,782,954)\n[기타포괄손익]\n30,343,930\n30,071,697\n29,965,013\n[이익잉여금]\n176,319,412\n171,755,984\n258,850,603\n자본총계\n402,354,445\n397,518,784\n484,506,719\n종속.관계.공동기업투자주식의 평가방법\r\n지분법\n지분법\n지분법\xa0\n(2020.1.1.~2020.09.30)\n(2019.1.1.~2019.12.31)\n(2018.1.1.~2018.12.31)\n영업수익\n13,302,937\n15,296,455\n13,062,295\n영업이익(손실)\n7,824,607\n8,252,180\n6,663,368\n당기순이익\n5,638,007\n(85,608,008)\n5,266,222\n기타포괄손익\n272,232\n(305,347)\n18,005,873\n총포괄손익\n5,910,239\n(85,913,355)\n23,272,095\n기본주당이익(원)\n367\n(5,577)\n1,015\n희석주당이익(원)\n367\n(5,577)\n1,015\n']"
